Occupational exposure to anticancer drug--potential and real hazards.
about
Comparative in vivo and in vitro sister chromatid exchange studies in chinese hamster bone marrow and spleen cellsCyclophosphamide-induced cytogenetic effects in mouse bone marrow and spleen cells in in vivo and in vivo/in vitro assaysHandling chemotherapy drugs-Do medical gloves really protect?Genotoxic Monitoring of Nurses Handling Cytotoxic DrugsOccupational risk in health care and research.Leukaemia and reproductive outcome among nurses handling antineoplastic drugs.Human effect monitoring in cases of occupational exposure to antineoplastic drugs: a method comparisonMercapturic acids, protein adducts, and DNA adducts as biomarkers of electrophilic chemicals.The risks of handling cytotoxic drugs. I. Methods of testing exposure.Micronucleus incidence and their chromosomal origin related to therapy in acute lymphoblastic leukemia (ALL) patients: detection by micronucleus and FISH techniques.Development of a new method for sampling and monitoring oncology staff exposed to cyclophosphamide drug.Human biological monitoring of occupational genotoxic exposures.Evaluation of the permeation of antineoplastic agents through medical gloves of varying materials and thickness and with varying surface treatments.Tannic acid mitigates cisplatin-induced nephrotoxicity in mice.Multicentre study for the evaluation of mutagenic/carcinogenic risk in nurses exposed to antineoplastic drugs: assessment of DNA damage.Determination of exposure of dispensary drug preparers to cyclophosphamide by passive sampling and liquid chromatography with tandem mass spectrometry.A new high-performance liquid chromatographic/electrospray ionization tandem mass spectrometric method for the simultaneous determination of cyclophosphamide, methotrexate and 5-fluorouracil as markers of surface contamination for occupational exposPhyllanthus maderaspatensis, a dietary supplement for the amelioration of adriamycin-induced toxicity and oxidative stress in mice.Highly sensitive high-performance liquid chromatography/selective reaction monitoring mass spectrometry method for the determination of cyclophosphamide and ifosfamide in urine of health care workers exposed to antineoplastic agents.Monitoring exposure of hospital personnel handling cytostatic drugs and contaminated materials.Comparison of three assays for genetic effects of antineoplastic drugs on cancer patients and their nurses.Immunotoxicity monitoring of hospital staff occupationally exposed to cytostatic drugs.Follow-up genotoxicological monitoring of nurses handling antineoplastic drugs.Investigating genetic damage in workers occupationally exposed to methotrexate using three genetic end-points.
P2860
Q23912946-2169AC4D-F1CB-4313-AB8D-38202C54E3B6Q23912947-AE05922D-CA18-4D0C-911C-F8ECDDB25E3DQ27686753-78936ADB-F758-488B-B454-B35B08C8757BQ28818024-6236CD94-DD21-4900-9EA9-4481E75F1655Q33186437-DFF59399-50AE-4272-B28B-82BD0C32682BQ33706849-CD1F665A-5F36-433B-B4A5-BECDAB1FA194Q35560680-C3D6F94F-4D10-42CD-8102-64406101CF97Q35662749-CD208398-95B5-439F-9093-29536BD4690DQ37797028-32FBD409-BE66-4F9D-BFFA-60357BF4A29CQ38491086-A0225AA4-74F6-48B3-BF8E-CC1BD0EA035EQ39898348-DFD767D9-51B4-4E5B-87B4-7452FEC0A87DQ40897256-E69482BD-C4A0-491C-8A39-920248763AA7Q42006874-6FE96B9A-065E-405F-9680-199D8E911B98Q42731229-CBE9690E-703C-4EE9-ACB0-D34CFA72D624Q44743404-14DC3564-3BE2-4665-847A-C840AEF437EFQ45145587-1AC3E625-89F6-470B-8905-9FB079D79AFBQ45288369-1F24A68D-2EC0-46B9-9183-E915FF9F877CQ46651151-D36504EB-2271-49B5-A500-3443DE45635DQ46688685-218D20C1-7AA8-4B8C-A1FD-ACBBB436DB30Q50145724-19FDD62B-3AB0-46D4-8729-C4780F5F719DQ50466454-F03D8740-1281-4077-B04F-65E2E1E4E950Q50786905-904F4E1E-199C-45A5-A6D5-0D145F897796Q53400467-5C128BC2-B4EF-47C5-B601-47A2002D9D7CQ53665227-07B5A793-82F9-47B7-9AA1-A1F433A0BB12
P2860
Occupational exposure to anticancer drug--potential and real hazards.
description
1985 nî lūn-bûn
@nan
1985年の論文
@ja
1985年学术文章
@wuu
1985年学术文章
@zh-cn
1985年学术文章
@zh-hans
1985年学术文章
@zh-my
1985年学术文章
@zh-sg
1985年學術文章
@yue
1985年學術文章
@zh
1985年學術文章
@zh-hant
name
Occupational exposure to anticancer drug--potential and real hazards.
@en
Occupational exposure to anticancer drug--potential and real hazards.
@nl
type
label
Occupational exposure to anticancer drug--potential and real hazards.
@en
Occupational exposure to anticancer drug--potential and real hazards.
@nl
prefLabel
Occupational exposure to anticancer drug--potential and real hazards.
@en
Occupational exposure to anticancer drug--potential and real hazards.
@nl
P2093
P1433
P1476
Occupational exposure to anticancer drug--potential and real hazards.
@en
P2093
P304
P356
10.1016/0165-1110(85)90024-7
P407
P577
1985-09-01T00:00:00Z